Order Article Reprints

Kuzuya T, Muto H, Tachi Y, Kobayashi M, Sugiyama H, Ariga M, Morisaki S, Komura G, Nakano T, Tanaka H, et al. Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy. Cancers. 2025; 17(24):3891. https://doi.org/10.3390/cancers17243891

Kuzuya, Teiji, Hisanori Muto, Yoshihiko Tachi, Mariko Kobayashi, Hijiri Sugiyama, Mizuki Ariga, Sayaka Morisaki, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, and et al. 2025. "Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy" Cancers 17, no. 24: 3891. https://doi.org/10.3390/cancers17243891

Kuzuya, T., Muto, H., Tachi, Y., Kobayashi, M., Sugiyama, H., Ariga, M., Morisaki, S., Komura, G., Nakano, T., Tanaka, H., Nakaoka, K., Ohno, E., Funasaka, K., Nagasaka, M., Miyahara, R., & Hirooka, Y. (2025). Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy. Cancers, 17(24), 3891. https://doi.org/10.3390/cancers17243891